HK1141211A1 - Novel seh inhibitors and their use - Google Patents
Novel seh inhibitors and their useInfo
- Publication number
- HK1141211A1 HK1141211A1 HK10107690.6A HK10107690A HK1141211A1 HK 1141211 A1 HK1141211 A1 HK 1141211A1 HK 10107690 A HK10107690 A HK 10107690A HK 1141211 A1 HK1141211 A1 HK 1141211A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- seh inhibitors
- novel seh
- novel
- inhibitors
- seh
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/46—Phenazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97915407P | 2007-10-11 | 2007-10-11 | |
PCT/US2008/079517 WO2009049157A1 (fr) | 2007-10-11 | 2008-10-10 | Nouveaux inhibiteurs de seh et leur utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1141211A1 true HK1141211A1 (en) | 2010-11-05 |
Family
ID=40549589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10107690.6A HK1141211A1 (en) | 2007-10-11 | 2010-08-11 | Novel seh inhibitors and their use |
Country Status (29)
Country | Link |
---|---|
US (2) | US8173805B2 (fr) |
EP (1) | EP2214487B1 (fr) |
JP (1) | JP5372943B2 (fr) |
KR (1) | KR101546111B1 (fr) |
CN (1) | CN101896065B (fr) |
AU (1) | AU2008310732B2 (fr) |
BR (1) | BRPI0817542A2 (fr) |
CA (1) | CA2702265C (fr) |
CO (1) | CO6270285A2 (fr) |
CR (1) | CR11423A (fr) |
CY (1) | CY1114865T1 (fr) |
DK (1) | DK2214487T3 (fr) |
DO (1) | DOP2010000101A (fr) |
EA (1) | EA018414B1 (fr) |
ES (1) | ES2445444T3 (fr) |
HK (1) | HK1141211A1 (fr) |
HR (1) | HRP20140105T1 (fr) |
IL (1) | IL204889A (fr) |
MA (1) | MA31761B1 (fr) |
MX (1) | MX2010003942A (fr) |
MY (1) | MY157116A (fr) |
NZ (1) | NZ584471A (fr) |
PL (1) | PL2214487T3 (fr) |
PT (1) | PT2214487E (fr) |
RS (1) | RS53180B (fr) |
SI (1) | SI2214487T1 (fr) |
UA (1) | UA107444C2 (fr) |
WO (1) | WO2009049157A1 (fr) |
ZA (1) | ZA201002465B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7994317B2 (en) | 2006-11-03 | 2011-08-09 | GlaxoSmithKline, LLC | sEH inhibitors and their use |
ES2445444T3 (es) * | 2007-10-11 | 2014-03-03 | Glaxosmithkline Llc | Nuevos inhibidores de sEH y su uso |
US8008483B2 (en) | 2007-10-11 | 2011-08-30 | GlaxoSmithKline, LLC | sEH inhibitors and their use |
FR2948027A1 (fr) | 2009-07-17 | 2011-01-21 | Merck Sante Sas | Derives amines de dihydro-1,3,5-triazine pour leur utilisation dans le traitement des maladies associees a une ischemie et/ou une reperfusion |
EP2567959B1 (fr) | 2011-09-12 | 2014-04-16 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
US8809552B2 (en) * | 2011-11-01 | 2014-08-19 | Hoffmann-La Roche Inc. | Azetidine compounds, compositions and methods of use |
WO2015003360A2 (fr) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Composés thérapeutiquement actifs et leurs méthodes d'utilisation |
US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
WO2015104422A1 (fr) | 2014-01-13 | 2015-07-16 | Basf Se | Composés dihydrothiophène dans la lutte contre des nuisibles invertébrés |
WO2015155129A1 (fr) * | 2014-04-07 | 2015-10-15 | Basf Se | Composé de diaminotriazine |
WO2016058544A1 (fr) | 2014-10-16 | 2016-04-21 | Syros Pharmaceuticals, Inc. | Inhibiteurs de la kinase cycline-dépendante 7 (cdk7) |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420283A (en) * | 1993-08-02 | 1995-05-30 | Pfizer Inc. | Resolution of (R)-2-benzylsuccinic acid 4-[4-(N-t-butoxycarbonylmethylamino)-piperidine] amide |
WO2000039102A1 (fr) * | 1998-12-23 | 2000-07-06 | Du Pont Pharmaceuticals Company | INHIBITEURS DE LA THROMBINE OU DU FACTEUR Xa |
ES2385931T3 (es) * | 2000-07-07 | 2012-08-03 | Spectrum Pharmaceuticals, Inc. | MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS. |
US6451814B1 (en) * | 2000-07-17 | 2002-09-17 | Wyeth | Heterocyclic β-3 adrenergic receptor agonists |
MX242553B (es) | 2000-10-20 | 2006-12-06 | Eisai Co Ltd | Derivados aromaticos que contienen nitrogeno. |
WO2002058736A2 (fr) * | 2000-12-12 | 2002-08-01 | Neotherapetics, Inc. | Utilisation d'analogues de purine a substitution en position 9 et d'autres molecules pour stimuler la neurogenese |
NZ526470A (en) | 2000-12-21 | 2006-03-31 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors |
CA2449486A1 (fr) * | 2001-06-29 | 2003-01-09 | Boehringer Ingelheim Pharmaceuticals Inc. | Procede d'utilisation d'inhibiteurs d'hydrolase epoxyde solubles |
US20030055249A1 (en) | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
ATE511858T1 (de) * | 2002-02-05 | 2011-06-15 | Astellas Pharma Inc | 2,4,6-triamino-1,3,5-triazin-derivat |
EP1505972A2 (fr) | 2002-05-16 | 2005-02-16 | Pharmacia Corporation | Methodes de traitement de maladies et de troubles respiratoires avec un inhibiteur inos selectif et un inhibiteur pde et compositions a cet effet |
EP1464335A3 (fr) | 2003-03-31 | 2007-05-09 | Taisho Pharmaceutical Co. Ltd. | Derivés de quinolines, tetrahydroquinolines et pyrimidines comme antagonistes du MCH |
MXPA06000051A (es) * | 2003-07-02 | 2006-03-21 | Vertex Pharma | Pirimidinas utiles como moduladores de canales ionicos dependientes de voltaje. |
US7223759B2 (en) * | 2003-09-15 | 2007-05-29 | Anadys Pharmaceuticals, Inc. | Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds |
CA2551037A1 (fr) * | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | Nouveau derive de piperidine |
GB0401269D0 (en) | 2004-01-21 | 2004-02-25 | Astrazeneca Ab | Compounds |
AU2005289426A1 (en) * | 2004-09-27 | 2006-04-06 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
US7919487B2 (en) | 2004-11-10 | 2011-04-05 | Synta Pharmaceuticals Corporation | Heteroaryl compounds |
AU2005316599A1 (en) | 2004-12-14 | 2006-06-22 | Vertex Pharmaceuticals Incorporated | Pyrimidine inhibitors of ERK protein kinase and uses therof |
JP2008540433A (ja) * | 2005-05-06 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 可溶性エポキシドヒドロラーゼインヒビター及びその使用方法 |
US20080280904A1 (en) * | 2005-10-07 | 2008-11-13 | Anne Bettina Eldrup | N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors |
US20090099184A1 (en) * | 2006-02-16 | 2009-04-16 | Boehringer Ingelheim International Gmbh | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
AR059826A1 (es) * | 2006-03-13 | 2008-04-30 | Univ California | Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble |
US7994317B2 (en) * | 2006-11-03 | 2011-08-09 | GlaxoSmithKline, LLC | sEH inhibitors and their use |
ES2445444T3 (es) * | 2007-10-11 | 2014-03-03 | Glaxosmithkline Llc | Nuevos inhibidores de sEH y su uso |
US20100210655A1 (en) * | 2007-10-11 | 2010-08-19 | Yun Ding | NOVEL sEH INHIBITORS AND THEIR USE |
US8008483B2 (en) * | 2007-10-11 | 2011-08-30 | GlaxoSmithKline, LLC | sEH inhibitors and their use |
WO2009048154A1 (fr) | 2007-10-12 | 2009-04-16 | Nec Corporation | Dispositif à semi-conducteurs et son procédé de conception |
WO2009070497A1 (fr) | 2007-11-28 | 2009-06-04 | Smithkline Beecham Corporation | Inhibiteurs de ehs et de 11β-hsd1 et leur utilisation |
JP2011506333A (ja) * | 2007-12-06 | 2011-03-03 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 新規sEH阻害剤およびその使用 |
JP2011510998A (ja) | 2008-01-30 | 2011-04-07 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 新規sEH阻害剤およびその使用 |
JP2011510997A (ja) * | 2008-01-30 | 2011-04-07 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 新規sEH阻害剤およびその使用 |
WO2009097474A1 (fr) | 2008-01-30 | 2009-08-06 | Smithkline Beecham Corporation | Nouveaux inhibiteurs de seh et leur utilisation |
WO2010011917A1 (fr) | 2008-07-25 | 2010-01-28 | Glaxosmithkline Llc | Inhibiteurs doubles de seh et 11β-hsd1 |
-
2008
- 2008-10-10 ES ES08838314.6T patent/ES2445444T3/es active Active
- 2008-10-10 KR KR1020107010233A patent/KR101546111B1/ko active IP Right Grant
- 2008-10-10 SI SI200831142T patent/SI2214487T1/sl unknown
- 2008-10-10 MX MX2010003942A patent/MX2010003942A/es active IP Right Grant
- 2008-10-10 EA EA201070442A patent/EA018414B1/ru not_active IP Right Cessation
- 2008-10-10 DK DK08838314.6T patent/DK2214487T3/da active
- 2008-10-10 AU AU2008310732A patent/AU2008310732B2/en active Active
- 2008-10-10 JP JP2010529081A patent/JP5372943B2/ja active Active
- 2008-10-10 RS RS20140078A patent/RS53180B/en unknown
- 2008-10-10 CN CN200880120430XA patent/CN101896065B/zh active Active
- 2008-10-10 EP EP08838314.6A patent/EP2214487B1/fr active Active
- 2008-10-10 BR BRPI0817542-0A2A patent/BRPI0817542A2/pt active Search and Examination
- 2008-10-10 CA CA2702265A patent/CA2702265C/fr active Active
- 2008-10-10 US US12/682,073 patent/US8173805B2/en active Active
- 2008-10-10 WO PCT/US2008/079517 patent/WO2009049157A1/fr active Application Filing
- 2008-10-10 PL PL08838314T patent/PL2214487T3/pl unknown
- 2008-10-10 NZ NZ584471A patent/NZ584471A/en unknown
- 2008-10-10 PT PT88383146T patent/PT2214487E/pt unknown
- 2008-10-10 UA UAA201005720A patent/UA107444C2/uk unknown
- 2008-10-10 MY MYPI2010001613A patent/MY157116A/en unknown
-
2010
- 2010-04-06 IL IL204889A patent/IL204889A/en active IP Right Grant
- 2010-04-08 MA MA32751A patent/MA31761B1/fr unknown
- 2010-04-08 ZA ZA2010/02465A patent/ZA201002465B/en unknown
- 2010-04-09 US US12/757,089 patent/US8212032B2/en active Active
- 2010-04-09 DO DO2010000101A patent/DOP2010000101A/es unknown
- 2010-05-06 CO CO10054262A patent/CO6270285A2/es active IP Right Grant
- 2010-05-11 CR CR11423A patent/CR11423A/es unknown
- 2010-08-11 HK HK10107690.6A patent/HK1141211A1/xx unknown
-
2014
- 2014-02-05 HR HRP20140105AT patent/HRP20140105T1/hr unknown
- 2014-02-18 CY CY20141100122T patent/CY1114865T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2224928A4 (fr) | Nouveaux inhibiteurs de seh et leur utilisation | |
TWI561237B (en) | Substituted dihydropyrazolones and their use | |
GB0701426D0 (en) | Compounds and their use | |
EP2200977A4 (fr) | Inhibiteur de f1f0-atpase et procédés associés | |
HK1141211A1 (en) | Novel seh inhibitors and their use | |
HK1208000A1 (en) | Thioninium compounds and their use | |
HK1137756A1 (en) | Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors hif--4- | |
EP2217068A4 (fr) | Nouveaux inhibiteurs de seh et leur utilisation | |
GB0611115D0 (en) | Compounds and their use | |
EP2209376A4 (fr) | Inhibiteurs inédits de la seh et leur utilisation | |
EP2213675A4 (fr) | Dérivé de pyridooxazépine et son utilisation | |
EP2097378A4 (fr) | Nouveaux inhibiteurs de seh et utilisation de ces derniers | |
EP2170874A4 (fr) | Nouveaux composés et leur utilisation | |
EP2133326A4 (fr) | Nouveau pseudoglycolipide et son utilisation | |
EP2240021A4 (fr) | Nouveaux inhibiteurs de seh et leur utilisation | |
EP2240026A4 (fr) | NOUVEAUX INHIBITEURS DE sEH ET LEUR UTILISATION | |
GB0619611D0 (en) | Compounds and their use | |
EP2240025A4 (fr) | NOUVEAUX INHIBITEURS DE sEH ET LEUR UTILISATION | |
EP2168951A4 (en) | AZOLYLMETHYLIDENHYDRAZINE DERIVATIVE AND ITS USE | |
HUP0600122A3 (en) | New compounds and their use | |
GB0722678D0 (en) | Compounds and their use II | |
GB0608846D0 (en) | Compounds and their use | |
GB0603378D0 (en) | Compounds and their use | |
GB0619609D0 (en) | Compounds and their use | |
GB0603376D0 (en) | Compounds and their use |